文献速递肝病消化道肿瘤与早癌

邮寄外展联合患者导航促进肝细胞癌筛查流程完成的多中心实用随机临床试验

Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial.
PubMed 文献 · Gut · 2024-11-11

本研究为多中心实用随机临床试验,纳入2872例肝硬化患者,比较邮寄外展联合患者导航(n=1436)与常规诊疗(n=1436)对肝细胞癌筛查流程完成的影响。结果显示干预组筛查流程完成率6.6% vs 常规组3.3%(OR 2.05,95%CI 1.44-2.92),筛查覆盖时间比例也显著更高(37.5% vs 28.2%;RR 1.33,95%CI 1.31-1.35),但两组筛查完成率仍不理想。

要点

  • 邮寄外展联合患者导航使肝硬化患者肝细胞癌筛查流程完成率从3.3%升至6.6%(OR 2.05)。
  • 干预组筛查覆盖时间比例37.5% vs 常规组28.2%,RR 1.33(95%CI 1.31-1.35)。
  • 多数亚组(年龄、性别、种族、Child-Turcotte-Pugh分级、卫生系统)干预效果一致。

核心结论

  • 邮寄外展联合患者导航较常规诊疗显著提高肝硬化患者肝细胞癌筛查流程完成率,多数亚组效果一致,但两组筛查完成率仍不理想,需要更强化干预。

研究设计与样本

  • 2018年4月至2021年9月在美国三个卫生系统开展的多中心实用随机临床试验,纳入肝硬化患者2872例,干预组1436例接受邮寄外展联合患者导航,对照组1436例接受常规诊疗及就诊时筛查,主要结局为36个月内筛查流程完成,次要结局为筛查覆盖时间比例,采用意向筛查分析。

主要发现

  • 全部2872例参与者(中位年龄61.3岁,女性32.3%)纳入意向筛查分析。
  • 干预组筛查流程完成率6.6%(95%CI 5.3%-7.9%),常规组3.3%(95%CI 2.4%-4.3%),OR 2.05(95%CI 1.44-2.92)。
  • 干预组筛查覆盖时间比例均值37.5%,常规组28.2%,RR 1.33(95%CI 1.31-1.35)。
  • 多数亚组(年龄、性别、种族和民族、Child-Turcotte-Pugh分级及卫生系统)中干预均提高筛查流程完成率。
  • 尽管筛查使用不足,两组多数肝细胞癌均在早期阶段检出。

临床怎么用

  • 作者认为邮寄外展联合患者导航可显著提高肝硬化患者肝细胞癌筛查流程完成率,但筛查完成率仍不理想,强调需要更强化干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatocellular carcinoma (HCC) is plagued by failures across the cancer care continuum, leading to frequent late-stage diagnoses and high mortality. We evaluated the effectiveness of mailed outreach invitations plus patient navigation to promote HCC screening process completion in patients with cirrhosis. METHODS: Between April 2018 and September 2021, we conducted a multicentre pragmatic randomised clinical trial comparing mailed outreach plus patient navigation for HCC screening (n=1436) versus usual care with visit-based screening (n=1436) among patients with cirrhosis at three US health systems. Our primary outcome was screening process completion over a 36-month period, and our secondary outcome was the proportion of time covered (PTC) by screening. All patients were included in intention-to-screen analyses. RESULTS: All 2872 participants (median age 61.3 years; 32.3% women) were included in intention-to-screen analyses. Screening process completion was observed in 6.6% (95% CI: 5.3% to 7.9%) of patients randomised to outreach and 3.3% (95% CI: 2.4% to 4.3%) of those randomised to usual care (OR 2.05, 95% CI: 1.44 to 2.92). The intervention increased HCC screening process completion across most subgroups including age, sex, race and ethnicity, Child-Turcotte-Pugh class and health system. PTC was also significantly higher in the outreach arm than usual care (mean 37.5% vs 28.2%; RR 1.33, 95% CI: 1.31 to 1.35). Despite screening underuse, most HCC in both arms were detected at an early stage. CONCLUSION: Mailed outreach plus navigation significantly increased HCC screening process completion versus usual care in patients with cirrhosis, with a consistent effect across most examined subgroups. However, screening completion remained suboptimal in both arms, underscoring a need for more intensive interventions. TRIAL REGISTRATION NUMBER: NCT02582918.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Singal AG, Narasimman M, Daher D, et al. Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial. Gut. 2024. PMID: 38839269. doi:10.1136/gutjnl-2024-332508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。